News

Eli Lilly will acquire gene-editing startup Verve Therapeutics for up to $1.3 billion, the companies said on Tuesday, to ...
Another Cambridge UK life science company has expanded its trade reach into China as a new Silk Road of trade re-opens.
Kraft Heinz said on Tuesday it would not launch products with artificial colours... Shares in the gene-editing starup Verve Therapeutics have soared more than 77 per... The total loan book of credit ...